(5alpha)-1-Methyl-3-oxoandrost-1-en-17-yl acetate(CAS: 434-05-9)

The compound (5alpha)-1-Methyl-3-oxoandrost-1-en-17-yl acetate (CAS: 434-05-9) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) in the EU, and requirements set by the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) in the USA. It is important to comply with local and international regulations for its handling, storage, and disposal.

In synthesis, alternatives to (5alpha)-1-Methyl-3-oxoandrost-1-en-17-yl acetate (CAS: 434-05-9) include similar steroidal acetates and other steroidal derivatives. Common alternative reagents and synthetic routes may involve using different precursors like androstenedione or other androstane derivatives, which can provide similar functional groups for analogous reactions.

The market for (5alpha)-1-Methyl-3-oxoandrost-1-en-17-yl acetate (CAS: 434-05-9) is primarily driven by its use in pharmaceutical and cosmetic industries. Recent research trends focus on its potential applications in hormone replacement therapy and as a precursor in steroid synthesis. The demand is expected to grow due to increasing interest in personalized medicine and cosmetic products with natural ingredients.

Waste containing (5alpha)-1-Methyl-3-oxoandrost-1-en-17-yl acetate (CAS: 434-05-9) should be handled according to local and international hazardous waste regulations. Collection and incineration by professional waste disposal services are recommended to ensure safe disposal. Proper environmental protection measures, such as preventing contamination of soil and water, should be implemented throughout the disposal process.